The novel approach of this peptide represents a major advance in the management of type 2 diabetes. Different to existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide976176.arwebo.com/64586825/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment